In 2024, Medicaid payments in Presque Isle reached a minimum of $38,868 for services billed with HCPCS codes specifically connected to COVID-19, based on information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. This was a 0.4% rise over 2023, during which $38,705 in claims for the same codes were reported by providers.
Medicaid is a public health insurance initiative managed by individual states and funded through both federal and state governments. The program offers coverage to low-income people and families, seniors, children, and those with disabilities, making it one of the nation’s largest health care components.
Because Medicaid expenditures are funded by taxpayers, local shifts in billing reflect how health care resources are directed within the community.
For this report, HCPCS codes with descriptions designated as “COVID-19” or “coronavirus” were used to quantify COVID-19 services. This means totals only include those clearly labeled as COVID-related in billing data; other pandemic-related care billed under wider or different codes is not included.
Elsewhere in Maine, Portland saw the highest Medicaid payments connected to COVID-19 offerings in 2024, reaching $160,221 in related claims.
In Presque Isle, two providers filed Medicaid claims linked with COVID-19–related services for 2024. Immunoassay emerged as the most frequently billed code, responsible for $32,477 of the total.
Average Medicaid payment per provider for COVID-19–specific services in Presque Isle came to $19,434, exceeding the state average of $9,649.
During the pandemic, COVID-19–labeled services constituted a key driver of Medicaid spending growth in Presque Isle.
Across all other claim categories, total Medicaid payments increased by $3,112,420 from 2020 to 2024, a 12.5% growth.
In the two years just before the pandemic, Presque Isle’s average annual Medicaid payments were $24,365,096.
According to the Centers for Medicare & Medicaid Services, state and federal Medicaid spending together totaled about $871.7 billion in fiscal year 2023, about 18% of all national health care expenditures. That marks a sharp increase from roughly $613.5 billion in 2019, prior to the global pandemic.
This change reflects approximately 40% growth in just a few years, mostly due to expanded enrollment and increased use of Medicaid services during and after the pandemic.
Recent federal budget law from the Trump administration brought several major proposals to reduce federal Medicaid spending and change its structure. For instance, the “One Big Beautiful Bill Act,” signed in 2025, is expected to reduce federal Medicaid expenditure by more than $1 trillion over the next decade and adds provisions such as work requirements and higher cost responsibilities for beneficiaries. These policies are likely to increase financial responsibility for states and curb the growth of federal Medicaid funding, although the program will still cover tens of millions of Americans.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $38,868 | 0.4% | $28,040,983 |
| 2023 | $38,705 | -86.9% | $31,183,606 |
| 2022 | $295,832 | -55.9% | $27,692,683 |
| 2021 | $670,192 | 382.2% | $26,573,037 |
| 2020 | $138,975 | N/A | $25,028,671 |
| 2019 | $0 | N/A | $25,729,583 |
| 2018 | $0 | N/A | $23,000,608 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $32,477 | 1,268 |
| 90480 | COVID-19 Vaccine Administration | $6,390 | 310 |
Note: Includes only HCPCS codes clearly marked for COVID-19 services. Totals do not encompass all spending linked to pandemic care.
This article’s data came from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Find the source data here.
